Table 1 Sample characteristics by user group for the total survey sample
Any substance users (n = 36,538) | Alcohol users (n = 35,753) | Tobacco users (n = 9816) | Cannabis users (n = 3289) | Other illegal drug users (n = 1961) | |
|---|---|---|---|---|---|
% (95% CI) or mean (95% CI) | |||||
Sex | |||||
Female | 51.6% (49.2, 54.0%) | 52.1% (49.7%,54.6%) | 46.6% (42.5, 50.7%) | 37.8% (30.5, 45.0%) | 36.0% (26.2, 45.8%) |
Male | 47.8% (45.0, 50.5%) | 47.2% (44.4, 50.0%) | 52.1% (47.8, 56.5%) | 59.9% (53.8, 65.9%) | 61.8% (54.0, 69.5%) |
Other | 0.6% (0.0, 4.4%) | 0.7% (0.0, 4.5%) | 1.3% (0.0, 7.6%) | 2.4% (0.0, 12.1%) | 2.3% (0.0, 14.2%) |
Age group | |||||
18–34 | 33.5% (30.4, 36.6%) | 34.2% (31.0, 37.3%) | 38.1% (33.1, 43.1%) | 54.6% (48.0, 61.1%) | 50.7% (41.8, 59.6%) |
35–54 | 43.4% (40.7, 46.1%) | 43.6% (40.9, 46.4%) | 42.4% (37.9, 46.8%) | 32.5% (25.0, 40.0%) | 35.4% (25.6, 45.2%) |
55+ | 23.1% (20.1, 26.1%) | 22.2% (19.1, 25.2%) | 19.5% (14.6, 24.4%) | 12.9% (4.4, 21.4%) | 13.9% (2.9, 24.9%) |
Education | |||||
Low | 10.6% (6.9, 14.2%) | 9.1% (5.4, 12.9%) | 15.5% (9.8, 21.3%) | 15.2% (5.9, 24.5%) | 15.6% (3.6, 27.5%) |
Middle | 44.1% (41.2, 47.1%) | 44.2% (41.1, 47.2%) | 47.4% (42.7, 52.0%) | 52.9% (46.0, 59.8%) | 53.3% (44.2, 62.4%) |
High | 45.3% (43.0, 47.7%) | 46.7% (44.3, 49.1%) | 37.1% (32.9, 41.3%) | 31.9% (25.3, 38.6%) | 31.1% (22.7, 39.6%) |
Personal income | |||||
Low | 52.5% (49.8, 55.2%) | 51.6% (48.8, 54.4%) | 58.7% (54.6, 62.8%) | 57.1% (50.6, 63.5%) | 58.3% (49.8, 66.8%) |
Middle | 24.9% (21.9, 27.9%) | 25.1% (22.1, 28.1%) | 22.7% (17.7, 27.8%) | 24.3% (16.0, 32.5%) | 21.4% (11.0, 31.8%) |
High | 22.6% (19.5, 25.6%) | 23.3% (20.2, 26.4%) | 18.5% (13.1, 23.9%) | 18.7% (10.3, 27.0%) | 20.3% (9.6, 31.0%) |
AUDIT-C sum score a | |||||
Mean | 4.5 (4.4, 4.5) | 4.5 (4.4, 4.5) | 5.2 (5.2, 5.3) | 5.5 (5.4, 5.6) | 5.7 (5.6, 5.8) |
Score = 8 or more | 17.8% (14.2, 21.4%) | 17.8% (14.2, 21.4%) | 25.8% (19.9, 31.6%) | 24.2% (15.4, 33.1%) | 28.5% (17.4, 39.5%) |
Restrictions in day-to-day life | |||||
not at all | 4.6% (0.4, 8.8%) | 3.9% (0.0, 8.2%) | 8.0% (1.1, 14.9%) | 11.3% (0.6, 22.1%) | 18.1% (4.8, 31.4%) |
to some degree | 25.6% (22.1, 29.0%) | 25.5% (21.9, 29.0%) | 24.2% (18.5, 30.0%) | 18.5% (9.2, 27.7%) | 15.2% (3.9, 26.4%) |
to a substantial degree | 33.1% (30.1, 36.0%) | 33.5% (30.5, 36.5%) | 32.0% (27.1, 36.9%) | 31.1% (23.4, 38.8%) | 32.1% (21.6, 42.7%) |
to a very high degree | 36.8% (34.2, 39.3%) | 37.1% (34.5, 39.7%) | 35.8% (31.5, 40.1%) | 39.1% (32.4, 45.8%) | 34.6% (25.9, 43.3%) |
Financial loss | |||||
not at all | 38.3% (35.6, 41.0%) | 37.9% (35.1, 40.7%) | 35.8% (31.1, 40.5%) | 38.5% (31.1, 45.9%) | 41.6% (32.0, 51.2%) |
to some degree | 34.8% (31.9, 37.8%) | 35.3% (32.3, 38.3%) | 32.3% (27.4, 37.3%) | 28.3% (20.5, 36.0%) | 21.4% (11.8, 31.1%) |
to a substantial degree | 15.3% (11.7, 18.8%) | 15.3% (11.7, 18.9%) | 17.4% (11.6, 23.2%) | 16.7% (7.4, 26.0%) | 20.0% (7.4, 32.5%) |
to a very high degree | 11.6% (8.2, 15.0%) | 11.5% (8.0, 15.0%) | 14.5% (8.9, 20.1%) | 16.5% (7.7, 25.3%) | 17.0% (5.9, 28.1%) |
Direct SARS-CoV-2 contact | 11.6% (8.1, 15.1%) | 11.6% (8.0, 15.1%) | 11.1% (5.3, 16.9%) | 11.7% (2.8, 20.6%) | 9.9% (0.0, 20.9%) |